KRAS mutation is not associated with recurrence or survival in 508 stage III colon cancers: Findings from multicenter adjuvant trial CALGB 89803

Ogino, S. ,  Meyerhardt, J. A. ,  Irahara, N. ,  Niedzwiecki, D. ... -  AMP   -  Annual Meeting Association of Molecular Pathology   -  2009    

Abstract -  Secondary -  Primary -  GI -  C89803